BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3620475)

  • 1. Fibrinogen-sepharose interaction with prothrombin, prethrombin 1, prethrombin 2 and thrombin.
    Kaczmarek E; Kaminski M; McDonagh J
    Biochim Biophys Acta; 1987 Aug; 914(3):275-82. PubMed ID: 3620475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of affinity chromatography for isolating prethrombin 1].
    Strukova SM; Mitroshina TN; Umarova VA; Kudriashov BA
    Vopr Med Khim; 1981; 27(6):840-4. PubMed ID: 7336661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activation by heparin-Sepharose of prothrombin conversion to prethrombin 1].
    Strukova SM; Mitroshina TN; Kudriashov BA
    Biokhimiia; 1981 May; 46(5):904-10. PubMed ID: 7295815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic properties of staphylothrombin, an active molecular complex formed between staphylocoagulase and human prothrombin.
    Kawabata S; Morita T; Iwanaga S; Igarashi H
    J Biochem; 1985 Dec; 98(6):1603-14. PubMed ID: 4093448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of recombinant alpha-thrombin: high-level expression of recombinant human prethrombin-2 and its activation by recombinant ecarin.
    Yonemura H; Imamura T; Soejima K; Nakahara Y; Morikawa W; Ushio Y; Kamachi Y; Nakatake H; Sugawara K; Nakagaki T; Nozaki C
    J Biochem; 2004 May; 135(5):577-82. PubMed ID: 15173195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and folding of recombinant bovine prethrombin-2 and its activation to thrombin.
    DiBella EE; Maurer MC; Scheraga HA
    J Biol Chem; 1995 Jan; 270(1):163-9. PubMed ID: 7814368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive development of a thrombin inhibitor binding site.
    Hibbard LS; Nesheim ME; Mann KG
    Biochemistry; 1982 May; 21(10):2285-92. PubMed ID: 6896460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
    Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
    Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient refolding method for the preparation of recombinant human prethrombin-2 and characterization of the recombinant-derived alpha-thrombin.
    Soejima K; Mimura N; Yonemura H; Nakatake H; Imamura T; Nozaki C
    J Biochem; 2001 Aug; 130(2):269-77. PubMed ID: 11481045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regions remote from the site of cleavage determine macromolecular substrate recognition by the prothrombinase complex.
    Betz A; Krishnaswamy S
    J Biol Chem; 1998 Apr; 273(17):10709-18. PubMed ID: 9553135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of alpha-thrombin and prethrombin 2, with phosphatidylserine-containing monolayers.
    Lecompte MF
    Biochimie; 1984 Feb; 66(2):105-9. PubMed ID: 6733153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interaction of human thrombin I fragment, prethrombin I, and alpha-thrombin with tissue thromboplastin].
    Timerbaev VN; Zubairov DM; Kiselev SV; Kirshin SV; Soboleva IV
    Biokhimiia; 1992 Jan; 57(1):77-90. PubMed ID: 1391207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site.
    Liu LW; Ye J; Johnson AE; Esmon CT
    J Biol Chem; 1991 Dec; 266(35):23633-6. PubMed ID: 1748641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation.
    Rosing J; Zwaal RF; Tans G
    J Biol Chem; 1986 Mar; 261(9):4224-8. PubMed ID: 3753979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of clotting factor V heavy chain with prothrombin and prethrombin 1 and role of activated protein C in regulating this interaction: analysis by analytical ultracentrifugation.
    Luckow EA; Lyons DA; Ridgeway TM; Esmon CT; Laue TM
    Biochemistry; 1989 Mar; 28(5):2348-54. PubMed ID: 2719956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes.
    Panizzi P; Friedrich R; Fuentes-Prior P; Richter K; Bock PE; Bode W
    J Biol Chem; 2006 Jan; 281(2):1179-87. PubMed ID: 16230339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable expression and purification of a secreted human recombinant prethrombin-2 and its activation to thrombin.
    Russo G; Gast A; Schlaeger EJ; Angiolillo A; Pietropaolo C
    Protein Expr Purif; 1997 Jul; 10(2):214-25. PubMed ID: 9226718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates.
    Hogg PJ; Jackson CM
    J Biol Chem; 1990 Jan; 265(1):248-55. PubMed ID: 2294105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin.
    Anderson PJ; Nesset A; Bock PE
    J Biol Chem; 2003 Nov; 278(45):44482-8. PubMed ID: 12939269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.